Free Trial

NeuroMetrix (NURO) Competitors

NeuroMetrix logo
$4.06 +0.01 (+0.25%)
As of 03:52 PM Eastern

NURO vs. COCH, SURG, POCI, IRIX, DRIO, XAIR, PTHL, CODX, BSGM, and FEMY

Should you be buying NeuroMetrix stock or one of its competitors? The main competitors of NeuroMetrix include Envoy Medical (COCH), SurgePays (SURG), Precision Optics (POCI), IRIDEX (IRIX), DarioHealth (DRIO), Beyond Air (XAIR), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Co-Diagnostics (CODX), BioSig Technologies (BSGM), and Femasys (FEMY). These companies are all part of the "medical equipment" industry.

NeuroMetrix vs.

Envoy Medical (NASDAQ:COCH) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk.

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are held by institutional investors. 60.5% of Envoy Medical shares are held by company insiders. Comparatively, 4.4% of NeuroMetrix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, NeuroMetrix had 2 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for NeuroMetrix and 0 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.00 beat NeuroMetrix's score of 0.33 indicating that Envoy Medical is being referred to more favorably in the media.

Company Overall Sentiment
Envoy Medical Positive
NeuroMetrix Neutral

NeuroMetrix has a net margin of -203.71% compared to Envoy Medical's net margin of -7,607.55%. Envoy Medical's return on equity of 0.00% beat NeuroMetrix's return on equity.

Company Net Margins Return on Equity Return on Assets
Envoy Medical-7,607.55% N/A -262.28%
NeuroMetrix -203.71%-42.56%-39.26%

NeuroMetrix has higher revenue and earnings than Envoy Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$320K91.76-$29.91MN/AN/A
NeuroMetrix$5.90M1.41-$6.53M-$4.59-0.89

Envoy Medical has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 2.2, meaning that its stock price is 120% more volatile than the S&P 500.

NeuroMetrix received 277 more outperform votes than Envoy Medical when rated by MarketBeat users. However, 100.00% of users gave Envoy Medical an outperform vote while only 57.96% of users gave NeuroMetrix an outperform vote.

CompanyUnderperformOutperform
Envoy MedicalOutperform Votes
7
100.00%
Underperform Votes
No Votes
NeuroMetrixOutperform Votes
284
57.96%
Underperform Votes
206
42.04%

Envoy Medical presently has a consensus target price of $8.00, suggesting a potential upside of 451.72%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than NeuroMetrix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
NeuroMetrix
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Envoy Medical beats NeuroMetrix on 9 of the 16 factors compared between the two stocks.

Get NeuroMetrix News Delivered to You Automatically

Sign up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NURO vs. The Competition

MetricNeuroMetrixSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$8.34M$4.83B$5.39B$9.14B
Dividend YieldN/A52.58%5.37%4.00%
P/E Ratio-0.8926.1388.1017.53
Price / Sales1.4161.291,285.4080.11
Price / CashN/A50.8936.6032.90
Price / Book0.317.894.954.67
Net Income-$6.53M$13.87M$117.96M$224.69M
7 Day Performance2.66%4.06%2.49%3.32%
1 Month Performance4.77%11.17%3.44%5.36%
1 Year Performance36.20%33.28%27.06%22.59%

NeuroMetrix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NURO
NeuroMetrix
0.4839 of 5 stars
$4.06
+0.2%
N/A+35.0%$8.28M$5.90M-0.8820Positive News
High Trading Volume
COCH
Envoy Medical
2.3491 of 5 stars
$1.58
+7.7%
$8.00
+405.4%
+4.7%$32.04M$278,000.000.0034
SURG
SurgePays
3.2768 of 5 stars
$1.58
-6.0%
$8.50
+438.0%
-75.2%$31.86M$83.60M-1.4040News Coverage
Positive News
POCI
Precision Optics
0.5259 of 5 stars
$4.88
+1.7%
N/A-19.6%$30.99M$18.98M-7.8780Positive News
Gap Down
IRIX
IRIDEX
0.5682 of 5 stars
$1.63
-1.0%
$2.00
+22.5%
-40.3%$27.17M$48.43M-2.44120Analyst Forecast
News Coverage
Positive News
DRIO
DarioHealth
2.5378 of 5 stars
$0.79
-14.1%
$4.00
+406.1%
-69.8%$26.95M$23.05M-0.84200News Coverage
Gap Up
XAIR
Beyond Air
4.3191 of 5 stars
$0.36
-6.3%
$3.67
+911.2%
-68.0%$26.18M$2.34M-0.2670News Coverage
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/A$3.90
-1.0%
N/AN/A$25.67M$572,291.000.0011Positive News
Gap Down
CODX
Co-Diagnostics
3.7248 of 5 stars
$0.76
-8.2%
$1.50
+96.9%
-34.8%$24.33M$7.32M-0.55100
BSGM
BioSig Technologies
1.5676 of 5 stars
$1.41
-2.1%
$2.75
+95.0%
-56.9%$24.30M$39,000.000.0050
FEMY
Femasys
3.3 of 5 stars
$1.05
-2.8%
$10.00
+852.4%
+38.8%$24.04M$1.26M-1.3030Positive News

Related Companies and Tools


This page (NASDAQ:NURO) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners